IDiyas

For the Inventor, By the Inventor

Oak Ridge, NC, United States of America

Adnan M M Mjalli

USPTO Granted Patents = 74 

 

Average Co-Inventor Count = 4.9

ph-index = 14

Forward Citations = 1,164(Granted Patents)

Forward Citations (Not Self Cited) = 1,089(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Jamestown, NC (US) (2001 - 2015)
  • Oak Ridge, NC (US) (2008 - 2023)

Company Filing History:

goldMedal33 out of 49 
 
Transtech Pharma, Inc.
 patents
silverMedal20 out of 52 
 
Vtv Therapeutics LLC
 patents
bronzeMedal11 out of 50 
 
High Point Pharmaceuticals, LLC
 patents
4. 4 out of 1,777 
 
Novo Nordisk A/s
 patents
5. 3 out of 6 
 
Advanced Syntech, LLC
 patents
6. 1 out of 1 
 
Transtech Pharm, Inc.
 patent
7. 1 out of 7 
 
Pharmacore, Inc.
 patents
8. 1 out of 832,680 
Other
 patents

Years Active: 2001-2024

Loading Chart...
Loading Chart...
74 patents (USPTO):
1. 12091407 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2024-09-17),
2. 11649230 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2023-05-16),
3. 11130753 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-09-28),
4. 10889580 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-01-12),
5. 10570126 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2020-02-25),
6. 10568888 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors (2020-02-25),
7. 10391097 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors (2019-08-27),
8. 10364233 - Piperidine derivative and methods of use thereof (2019-07-30),
9. 10363244 - Compositions comprising metformin and a glucokinase activator (2019-07-30),
10. 10287284 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2019-05-14),
11. 10085990 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2018-10-02),
12. 10064846 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2018-09-04),
13. 9855251 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2018-01-02),
14. 9833457 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2017-12-05),
15. 9687489 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2017-06-27),

Title: The Innovative Journey of Adnan M M Mjalli

Introduction:

Adnan M M Mjalli, a distinguished inventor hailing from Oak Ridge, NC (US), has made significant contributions to the field of innovations and patents through his groundbreaking work.

Latest Patents:

Adnan M M Mjalli holds several patents in various industries, showcasing his versatility and ingenuity in inventing new technologies to solve complex problems.

Career Highlights:

With a career spanning several decades, Adnan M M Mjalli has established himself as a visionary inventor known for his out-of-the-box thinking and ability to transform ideas into tangible inventions that have real-world applications.

Collaborations:

Throughout his career, Adnan M M Mjalli has collaborated with leading research institutions, universities, and companies to further his innovative projects and bring his inventions to the market, solidifying his reputation as a respected figure in the world of patents.

Conclusion:

In conclusion, Adnan M M Mjalli's relentless pursuit of innovation and his passion for creating solutions that make a difference have cemented his legacy as a pioneering inventor whose work continues to inspire future generations in the realm of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…